INVO Fertility, Inc. Insider Trading

IVF

Last 12 months

Insiders sold $6 and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Matthew K Szot sold $6 on Dec 3, 2025, 100% of their stake, outside a plan. The last open-market buy by an executive or director was in Jun 2022.

Net open-market

−$6

0 buys · 1 sale

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

Jun 2022

Jun 1, 2022

Get an email when IVF's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Dec 3, 2025	Matthew K Szot Director	SoldNo plan	4	$1.52	$6	100%	Form 4

Dec 3, 2025No plan
Matthew K Szot
Director · sold 4 at $1.52
$6
100% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch IVF, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with IVF

CompareIntrinsic value

XAIRBeyond Air, Inc.

$2.33+0.43%30

ECIAEncision Inc.

$0.03+160.87%14

PMIPicard Medical, Inc.

$7.19-7.58%30

NMTCNeuroOne Medical Technologies Corporation

$0.95-3.06%40

LUCDLucid Diagnostics Inc.

$0.44+8.80%44

TNONTenon Medical Inc.

$1.91+1.06%40

AURXNuo Therapeutics Inc.

$1.27+0.00%40

MDNCMedinotec Inc.

No recent price65

Spot a number that looks wrong? Check it in IVF's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing IVF

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.